BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cichero E, Tonelli M. Targeting species-specific trace amine-associated receptor 1 ligands: to date perspective of the rational drug design process. Future Medicinal Chemistry 2017;9:1507-27. [DOI: 10.4155/fmc-2017-0044] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alnefeesi Y, Tamura JK, Lui LMW, Jawad MY, Ceban F, Ling S, Nasri F, Rosenblat JD, McIntyre RS. Trace amine-associated receptor 1 (TAAR1): Potential application in mood disorders: A systematic review. Neurosci Biobehav Rev 2021;131:192-210. [PMID: 34537265 DOI: 10.1016/j.neubiorev.2021.09.020] [Reference Citation Analysis]
2 Zendehdel M, Hassanpour S, Movahedi N. Central and peripheral methylamine-induced hypophagia is mediated via nitric oxide and TAAR1 in neonatal layer-type chicken. Neurosci Lett 2020;739:135408. [PMID: 33027685 DOI: 10.1016/j.neulet.2020.135408] [Reference Citation Analysis]
3 Cichero E. Opportunities and challenges in the design of selective TAAR1 agonists: an editorial. Expert Opinion on Therapeutic Patents 2018;28:437-40. [DOI: 10.1080/13543776.2018.1476493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cai D, Liu L, Han C, Ma X, Qian J, Zhou J, Zhu W. Cancer cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the combination of Chemo/Magnetocaloric therapy on MDA-MB-231 cells. Sci Rep 2019;9:14475. [PMID: 31597929 DOI: 10.1038/s41598-019-51029-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
5 Zhang X, Mantas I, Alvarsson A, Yoshitake T, Shariatgorji M, Pereira M, Nilsson A, Kehr J, Andrén PE, Millan MJ, Chergui K, Svenningsson P. Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine. Front Pharmacol 2018;9:166. [PMID: 29545750 DOI: 10.3389/fphar.2018.00166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Xu Z, Li Q. TAAR Agonists. Cell Mol Neurobiol 2020;40:257-72. [PMID: 31848873 DOI: 10.1007/s10571-019-00774-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Francesconi V, Cichero E, Kanov EV, Laurini E, Pricl S, Gainetdinov RR, Tonelli M. Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies. Pharmaceuticals (Basel) 2020;13:E391. [PMID: 33202687 DOI: 10.3390/ph13110391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
8 Tonelli M, Cichero E. Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present). Expert Opinion on Therapeutic Patents 2020;30:137-45. [DOI: 10.1080/13543776.2020.1708900] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
9 Guariento S, Tonelli M, Espinoza S, Gerasimov AS, Gainetdinov RR, Cichero E. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists. European Journal of Medicinal Chemistry 2018;146:171-84. [DOI: 10.1016/j.ejmech.2018.01.059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]